NCT04975217 2026-03-20
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
Clinical Trials
11 trialsNCT07463248 2026-03-11
PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy
West China Hospital
Phase 2 Not yet recruiting
NCT07319364 2026-01-06
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1 Recruiting
NCT04729322 2025-12-23
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05690048 2025-08-06
FLORA
University Hospital Heidelberg
Phase 2 Recruiting
NCT06346093 2025-06-10
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
Changhai Hospital
Phase NA Recruiting
NCT06960122 2025-05-07
FMT-TP
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Not yet recruiting
NCT06405113 2025-02-20
FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
Changzhou No.2 People's Hospital
Phase 2 Recruiting
NCT04130763 2024-09-24
Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1
Peking University
Phase 1 Completed
NCT05279677 2022-08-23
FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage
ChineseAMS
Phase 2 Unknown
NCT05001360 2021-10-27
Study of FMT Combined With Nivolumab in Gastric Cancer
Fujian Cancer Hospital
Phase NA Withdrawn